Institutional Ownership Cogent Biosciences, Inc. (COGT)
This table provides information about the institutional ownership of Cogent Biosciences, Inc. (COGT). We have compiled data on the 171 institutions that hold shares in the stock, with a total of 113 Million shares, which have been reported (via 13F filing form) to have a value of $1.02 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Nov 14, 2024 Q3 2024 |
10,470,398
shares
|
$95.1 Million
0.31% of portfolio
|
Q2 2024
Reduced 30.13%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Nov 14, 2024 Q3 2024 |
9,239,731
shares
|
$83.9 Million
8.19% of portfolio
|
Q3 2024
Reduced 0.22%
|
|
|
Commodore Capital LP
New York, NY |
Nov 14, 2024 Q3 2024 |
7,539,930
shares
|
$68.5 Million
6.92% of portfolio
|
Q3 2024
Reduced 22.57%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
7,288,378
shares
|
$66.2 Million
0.0% of portfolio
|
Q2 2024
Added 8.95%
|
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Nov 14, 2024 Q3 2024 |
6,964,375
shares
|
$63.2 Million
9.76% of portfolio
|
Q2 2024
Added 12.07%
|
|
|
Fairmount Funds Management LLC
Philadelphia, PA |
Nov 14, 2024 Q3 2024 |
6,225,641
shares
|
$56.5 Million
10.93% of portfolio
|
Q2 2024
Added 31.74%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
5,714,405
shares
|
$51.9 Million
0.0% of portfolio
|
Q3 2024
Added 8.64%
|
|
|
Vr Adviser, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
5,684,167
shares
|
$51.6 Million
6.36% of portfolio
|
Q2 2024
Added 10.82%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
4,609,762
shares
|
$41.9 Million
1.79% of portfolio
|
Q3 2024
Added 27.19%
|
|
|
Redmile Group, LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
4,484,380
shares
|
$40.7 Million
3.17% of portfolio
|
Q3 2024
Reduced 6.57%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2024 Q3 2024 |
4,066,034
shares
|
$36.9 Million
0.08% of portfolio
|
Q3 2024
Reduced 4.3%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Nov 14, 2024 Q3 2024 |
3,744,263
shares
|
$34 Million
0.75% of portfolio
|
Q2 2024
Added 144.03%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
3,231,462
shares
|
$29.3 Million
0.0% of portfolio
|
Q3 2024
Reduced 15.78%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
2,280,793
shares
|
$20.7 Million
0.0% of portfolio
|
Q3 2024
Added 15.15%
|
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Nov 13, 2024 Q3 2024 |
2,265,230
shares
|
$20.6 Million
2.31% of portfolio
|
Q3 2024
Reduced 18.32%
|
|
|
Logos Global Management LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
2,000,000
shares
|
$18.2 Million
2.86% of portfolio
|
Q3 2024
New holding
|
|
|
Saturn V Capital Management LLC
Austin, TX |
Nov 14, 2024 Q3 2024 |
1,712,899
shares
|
$15.6 Million
6.61% of portfolio
|
Q3 2024
Added 2.33%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
1,613,616
shares
|
$14.7 Million
0.01% of portfolio
|
Q3 2024
Added 30.99%
|
|
|
Octagon Capital Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
1,305,000
shares
|
$11.8 Million
3.4% of portfolio
|
Q3 2024
New holding
|
|
|
Silverarc Capital Management, LLC
|
Nov 14, 2024 Q3 2024 |
1,221,362
shares
|
$11.1 Million
3.28% of portfolio
|
Q3 2024
Added 1.26%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
Nov 13, 2024 Q3 2024 |
1,122,471
shares
|
$10.2 Million
1.77% of portfolio
|
Q3 2024
Reduced 50.0%
|
|
|
Avidity Partners Management LP
Dallas, TX |
Nov 14, 2024 Q3 2024 |
1,001,000
shares
|
$9.09 Million
0.66% of portfolio
|
Q3 2024
Added 0.03%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 12, 2024 Q3 2024 |
1,000,167
shares
|
$9.08 Million
0.0% of portfolio
|
Q3 2024
Added 0.01%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 15, 2024 Q3 2024 |
936,576
shares
|
$8.5 Million
0.54% of portfolio
|
Q1 2024
Reduced 53.06%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
Nov 14, 2024 Q3 2024 |
919,635
shares
|
$8.35 Million
0.18% of portfolio
|
Q3 2024
Reduced 34.26%
|